PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE
LaoBiz.com profiles the Laos Patent “PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE” from open registry fields, filed by CHONG KUN DANG PHARMACEUTICAL CORP. on 2016-08-24; current status: Awaiting formal examination. Identifiers include application No. P/581; DIP id LAP581; protection kind Patent - PCT National Phase. Key dates: publication 2026-01-16. Classification: A61K 31/155、A61K 31/426、A61K 31/506、A61K 47/38、A61K 9/28. Inventor(s)/designer(s): CHO, Min Kwan, LIM, Jong Lae, PARK, Shin Jung, SHIN, Eun Ji, SHIN, Teak Hwan. Abstract hint: The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobegl…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
P/581
Mark
Key facts
- Type
- Patent
- App. no.
P/581- Status
- Awaiting formal examination
- Applicant
- CHONG KUN DANG PHARMACEUTICAL CORP.
- Agent
- CONCETTI-LAO CO., LTD
- Filing date
- 2016-08-24
- Publication
- 2026-01-16
- Protection kind
- Patent - PCT National Phase
- Priority
- KR · 10-2015-0150108 · 2015-10-28
- Applicant address
- CHONG KUN DANG PHARMACEUTICAL CORP. · 8, Chungjeong-ro, Seodaemun-gu, Seoul 03742, Republic of Korea · KR
- Agent address
- CONCETTI-LAO CO., LTD · Lao-Thai Friendship Road, Sokpaluang Village,Sisattanak District, Vientiane Lao PDR, Tel: 312 383 · LA
- Nice / IPC classes
- A61K 31/155 · A61K 31/426 · A61K 31/506 · A61K 47/38 · A61K 9/28
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobeglit-azone or a pharmaceutically acceptable salt thereof and a pharmaceutical formula-tion comprising the same. The parma-ceutical composition can exhibit a syner-gistic effeet on glycemic control and can block the poten potential of side effts and the pharmaceutical formulation can be provide in the form of a combination for-mulation that is able to be administered once a day to thus improve medication compliance.
The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobeglit-azone or a pharmaceutically acceptable salt thereof and a pharmaceutical formula-tion comprising the same. The parma-ceutical composition can exhibit a syner-gistic effeet on glycemic control and can block the poten potential of side effts and the pharmaceutical formulation can be provide in the form of a combination for-mulation that is able to be administered once a day to thus improve medication compliance.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP581.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP581.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP581.html?lang=en · CC BY 4.0